| Cat# |
DIA-891 |
| Descriptions |
UDP-GalNAc: Beta-1, 3-N-acetylgalactosaminyltransferase 2 (B3GALNT2) catalyzes the transfer of N-acetylgalactosamine via β-1,3 linkage to glycan acceptors, participates in the biosynthesis of the GalNAcβ1-3Gal structure, and is associated with muscular dystrophy and neural glycosylation regulation. |
| Applications |
UDP-GalNAc: Beta-1, 3-N-acetylgalactosaminyltransferase 2 (B3GALNT2) is applied in muscular dystrophy related glycosylation detection kits and neural glycan biosynthesis assay reagent development. |
| CAS No. |
24-01-3138 |
| Enzyme Commission Number |
EC 2.4.1.313 |
| Enzyme Source |
Chinese Hamster Ovary cell line, CHO-derived human B3GALNT2 protein. |
| Reaction |
3-O- (N-acetyl-beta-D-glucosaminyl- (1->4)-alpha-D-mannosyl)-L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-[beta-D-GalNAc- (1->3)-beta-D-GlcNAc- (1->4)-alpha-D-Man]-L-Thr-[protein] + H+ + UDP |
| Activity Definition |
Measured by its ability to transfer GalNAc from UDP-GalNAc to benzyl-GlcNAc. |
| Download Datasheet: |
 |